UCH
Aurora, Colorado, 80020, United States
NCT Number: NCT02675985
This study will investigate the safety and feasibility of early intensive physical therapy for patients diagnosed with subarachnoid hemorrhage. Intervention will begin in the neurological Intensive Care Unit (ICU) and continue for 30 days or hospital discharge.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Aurora, Colorado, 80020, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Early Intensive Physical therapy in the ICU
Time frame: Every 7 days until hospital discharge or 28 days of study enrollment
Time frame: Every 7 days until hospital discharge or 28 days of study enrollment
Time frame: Every 7 days until hospital discharge or 28 days of study enrollment
Time frame: Every 7 days until hospital discharge or 28 days of study enrollment
Time frame: Every 7 days until hospital discharge or 28 days of study enrollment
Time frame: Every 7 days until hospital discharge or 28 days of study enrollment
Time frame: Hospital Discharge only
Neuro-QOL measures 17 domains of health related quality of life for adults through self-report.. We will use the short form versions for applied cognition, lower extremity mobility and Upper extremity function and Satisfaction with social roles/activities.
University of Colorado, Denver
Other
Effects of Early Intensive Physical Therapy for Patients With Subarachnoid Hemorrhage in a Neurological ICU
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02894034
Brain Diseases, Cardiovascular Diseases
Amiens, France
View Trial DetailsNCT03655509
Brain Diseases, Cardiovascular Diseases
Rennes, France
View Trial DetailsNCT04042571
Brain Diseases, Cardiovascular Diseases
Bordeaux, France
View Trial DetailsNCT06797765
Brain Diseases, Cardiovascular Diseases
Dallas, Texas, United States
View Trial Details